A generic antidepressant and a gout medicine that garnered some popularity as Covid-19 treatments shouldn’t be used for mild infection because there’s no evidence they help, according to a panel of experts advising the
The drugs, fluvoxamine and colchicine, could potentially cause harm, the group of experts said in the BMJ medical journal Thursday. The panel didn’t give advice for severe illness, saying there was a lack of data.
The two medicines “are commonly used, inexpensive drugs that have received considerable interest as potential Covid-19 treatments during the pandemic,” the WHO said.
Fluvoxamine is used for ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.